ZYME · Zymeworks Inc. · Executive Compensation
Market Cap
$2.07B
Shares
70.96M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Kenneth Galbraith | CEO, President & Chair | $5,253,616 |
| Leone Patterson | Exec. VP, Chief Business Officer & CFO | $2,907,982 |
| Paul Moore | CSO | $1,986,803 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Kenneth Galbraith | Chair, President & CEO | $3,374,876 |
| Neil Klompas | Former President & COO | $2,125,732 |
| Paul Moore | CSO | $1,682,237 |
| Christopher Astle | Former SVP & CFO | $1,191,820 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Kenneth Galbraith | Chair, President & CEO | $7,125,457 |
| Neil Klompas | Former President & COO | $1,808,408 |
| Christopher Astle | Former SVP & CFO | $1,315,005 |
| Ali Tehrani | Former President & CEO ^ ^ | $964,243 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Ali Tehrani | Former President & CEO ^ ^ | $5,110,637 |
| Neil Josephson | Chief Medical Officer | $3,547,690 |
| Anthony Polverino | Former Executive VP, Early Development & Chief ScientificOfficer | $1,917,908 |
| Neil Klompas | Former President & COO ^ ^ | $1,900,478 |
| Diana Hausman | Former Chief Medical Officer | $1,646,089 |
| James Priour | Former Chief Commercial Officer | $1,541,343 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Ali Tehrani | Former President & CEO | $4,877,459 |
| Diana Hausman | Former Chief Medical Officer | $1,933,847 |
| Anthony Polverino | Former Executive VP, Early Development & Chief ScientificOfficer | $1,903,941 |
| Neil Klompas | President and Chief Operating Officer (former CFO) | $1,887,097 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Ali Tehrani | Former President & CEO | $3,278,069 |
| Neil Klompas | President and Chief Operating Officer (former CFO) | $1,624,174 |
| Diana Hausman | Former Chief Medical Officer | $1,404,525 |
| Anthony Polverino | Former Executive VP, Early Development & Chief ScientificOfficer | $1,336,403 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Kristin Stafford | Executive Vice President, Chief Financial Officer | Appointed | 2026-04-01 |
| Sabeen Mekan | Senior Vice President and Chief Medical Officer | Appointed | 2026-01-12 |
| Mark Hollywood | Executive Vice President and Chief Operating Officer | Appointed | 2026-01-12 |
| Jeffrey Smith | Executive Vice President and Chief Medical Officer | Retired | 2026-01-12 |
| Kenneth Galbraith | interim Chief Financial Officer | Appointed | 2026-01-12 |
| Leone Patterson | Executive Vice President, Chief Business Officer and Chief Financial Officer | Terminated | 2026-01-12 |
| Brian Cherry | Class II director | Appointed | 2026-01-12 |
| Scott Platshon | Acting Chief Investment Officer | Appointed | 2025-11-18 |
| Scott Platshon | board of directors | Resigned | 2025-11-18 |
| Greg Ciongoli | Board of Directors | Appointed | 2025-08-11 |
| Troy M. Cox | Board | Resigned | 2025-08-11 |
| Robert E. Landry | director of the Company | Appointed | 2025-08-11 |
| Gregory A. Ciongoli | director of the Company | Appointed | 2025-08-11 |
| Scott Platshon | Compensation Committee member | Appointed | 2025-02-18 |
| Oleg Nodelman | director | Appointed | 2025-02-18 |
Key facts
CIK
1937653
CUSIP
98985Y108
13F (30d)
131 filings
130 filers
Visit website
Investor relations